Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

Z. Yao, L. Deng, Z. Y. Xu-Monette, G. C. Manyam, P. Jain, A. Tzankov, C. Visco, G. Bhagat, J. Wang, K. Dybkaer, W. Tam, E. D. Hsi, J. H. Van Krieken, M. Ponzoni, A. J.M. Ferreri, M. B. Møller, J. N. Winter, M. A. Piris, L. Fayad, Y. LiuY. Song*, R. Z. Orlowski, H. Kantarjian, L. J. Medeiros, Y. Li, J. Cortes, K. H. Young

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences